Search the NeLM

Medicines A-Z
Find key information about medicines by name (prototype)
NeLM news service
MeReC Bulletin: Implementing key therapeutic topics – antipsychotics in dementia, statins & ezetimibe, and hypnotics

Source: NPC

Date published: 17/02/2012 17:12

Summary
by: Devika Sennik

This Bulletin is the second of three MeReC Bulletins which support the Quality, Innovation, Productivity and Prevention (QIPP) agenda. The bulletin focuses on three of the key prescribing topics outlined in the NPC document, Key therapeutic topics - Medicines management options for local implementation.

 

The topics included in this Bulletin are:

 

• Antipsychotics in dementia

• Statins and ezetimibe

• Hypnotics

 

The third bulletin will cover hypoglycaemic agents; long-acting insulin analogues; and self-monitoring of blood glucose in type 2 diabetes.

Bulletin

Preview your comment

Add new comment

Comment text:

Comments

There are no comments yet. You could be the first! You must be Logged In to comment.
Related evidence
2.12 Lipid-regulating drugs
13/03/2012
SMC accepts atorvastatin chewable tablets (Lipitor®)
02/02/2012
Bezafibrate for primary biliary cirrhosis
19/01/2012
AWMSG issues Final Appraisal Recommendation on rosuvastatin (Crestor®)
4.1 Hypnotics and anxiolytics
22/03/2012
SIGN guideline: Management of perinatal mood disorders
18/11/2011
Melatonin for non-respiratory sleep disorders in visually impaired children
08/02/2011
New CKS Topic: Delirium
4.11 Drugs for dementia
09/11/2011
Updated PRODIGY (formerly CKS) topic on dementia
01/04/2011
Almitrine-Raubasine combination for dementia
23/03/2011
NICE issues guidance on the use of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer’s disease
Dementia
01/04/2011
Almitrine-Raubasine combination for dementia
30/07/2010
NICE quality standard on dementia care
10/08/2009
Vinpocetine for cognitive impairment and dementia
Hyperlipidaemia
13/03/2012
SMC accepts atorvastatin chewable tablets (Lipitor®)
19/01/2012
AWMSG issues Final Appraisal Recommendation on rosuvastatin (Crestor®)
11/10/2011
Scottish Medicines Consortium does not recommend rosuvastatin (Crestor®) for use in NHS Scotland for prevention of major cardiovascular events
Ischaemic heart disease
17/01/2012
SMC does not recommend ranolazine (Ranexa®) as an add-on for stable angina
26/10/2011
NICE issues guidance on ticagrelor for the treatment of acute coronary syndromes (ACS) – TA 236
26/10/2011
NICE issues clinical guideline on the management of hyperglycaemia in people with acute coronary syndromes (CG 130)
Sleep disorders
28/05/2010
Sodium oxybate (Xyrem®) in the management of narcolepsy with cataplexy
11/02/2009
MTRAC verdict – Melatonin (Circadin™) for primary insomnia
12/12/2008
A systematic review of the effectiveness of oral melatonin for adults (18 to 65 years) with delayed sleep phase syndrome and adults (18 to 65 years) with primary insomnia
Related news
2.12 Lipid-regulating drugs
21/05/2012
British Heart Foundation survey: One in three cholesterol patients 'do not take their medication'
18/05/2012
Review: Secondary prevention after ischaemic stroke or transient ischaemic attack
18/05/2012
Review: Diabetic neuropathy- clinical manifestations and current treatments
4.1 Hypnotics and anxiolytics
30/04/2012
Cohort study: Benzodiazepine exposure during breast-feeding not associated with increased CNS depression in infants
23/04/2012
Illicit Valium linked to hospitalisations in Scotland
10/04/2012
JCO reviews: Evidence-based treatment of anxiety, depression and delirium in patients with cancer
4.11 Drugs for dementia
11/05/2012
RCT: Efficacy of memantine for agitation in Alzheimer’s dementia
02/05/2012
BMJ Practice: Cholinesterase inhibitors and memantine for dementia
17/04/2012
WHO and Alzheimer’s Disease International publish report highlighting dementia as a public health priority
Dementia
17/05/2012
Horizon scanning: First Alzheimer's prevention trial - to investigate crenezumab - planned
11/05/2012
RCT: Efficacy of memantine for agitation in Alzheimer’s dementia
11/05/2012
NHS Evidence Update (April 2012) of NICE guideline on the diagnosis, prevention and management of delirium
Hyperlipidaemia
21/05/2012
British Heart Foundation survey: One in three cholesterol patients 'do not take their medication'
17/05/2012
Meta-analysis: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease
17/05/2012
Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study
Ischaemic heart disease
24/05/2012
Associations of dietary calcium intake and calcium supplementation with myocardial infarction and stroke risk
24/05/2012
Horizon scanning: FDA advisory panel recommends against approval of rivaroxaban to reduce the risk of secondary cardiovascular events in patients with acute coronary syndrome
17/05/2012
Meta-analysis: The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease
Sleep disorders
28/02/2012
Cohort study: Hypnotics and association with mortality or cancer
09/05/2011
Conference report: Positive phase IV data for armodafinil (Nuvigil®) for excessive sleepiness associated with shift work disorder
18/04/2011
European CHMP recommends interim amendment of product information on Pandemrix to warn of narcolepsy risk
Back